Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
Weickhardt AJ, Doebele RC, Purcell WT, Bunn PA, Oton AB, Rothman MS, Wierman ME, Mok T, Popat S, Bauman J, Nieva J, Novello S, Ou SH, Camidge DR.
Weickhardt AJ, et al. Among authors: rothman ms.
Cancer. 2013 Jul 1;119(13):2383-90. doi: 10.1002/cncr.28089. Epub 2013 Apr 12.
Cancer. 2013.
PMID: 23585220
Free PMC article.